BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 22425713)

  • 1. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
    Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
    Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
    Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
    Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Induced Pluripotent Stem Cells from Bovine Epithelial Cells and Partial Redirection Toward a Mammary Phenotype In Vitro.
    Cravero D; Martignani E; Miretti S; Accornero P; Pauciullo A; Sharma R; Donadeu FX; Baratta M
    Cell Reprogram; 2015 Jun; 17(3):211-20. PubMed ID: 26053520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
    Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
    Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells.
    Nagata S; Toyoda M; Yamaguchi S; Hirano K; Makino H; Nishino K; Miyagawa Y; Okita H; Kiyokawa N; Nakagawa M; Yamanaka S; Akutsu H; Umezawa A; Tada T
    Genes Cells; 2009 Dec; 14(12):1395-404. PubMed ID: 19912344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
    Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
    Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
    Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
    Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
    Li F; Bronson S; Niyibizi C
    J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
    Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
    Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.